AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression
Open Access
- 11 December 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 16 (3), 426-436
- https://doi.org/10.1038/gt.2008.174
Abstract
Periodontal disease is a chronic inflammatory condition induced by tooth-associated microbial biofilms that induce a host immune response. Therapeutic control of progressive tissue destruction in high-risk patients is a significant challenge in therapy. Soluble protein delivery of antagonists to tumor necrosis factor-α (TNF-α) inhibits alveolar bone resorption due to periodontitis. However, protein therapy raises several concerns, such as recurrence of disease activity after treatment cessation and repeated dosing regimens. In this study, we used pseudotyped adeno-associated virus vector based on serotype 1 (AAV2/1) to deliver the TNF receptor-immunoglobulin Fc (TNFR:Fc) fusion gene to rats subjected to experimental Porphyromonas gingivalis (Pg)-lipopolysaccharide (LPS)-mediated bone loss. Animals received Pg-LPS delivered to the gingivae thrice weekly for 8 weeks, vehicle alone, Pg-LPS and intramuscular delivery of pseudotyped AAV2/1-TNFR:Fc vector (1 × 1011 DNase I-resistant particles) or AAV2/1-TNFR:Fc vector delivered to naive animals. AAV2/1-TNFR:Fc therapy led to sustained therapeutic levels of serum TNFR protein and protected against Pg-LPS-mediated loss of bone volume and density. Furthermore, AAV2/1-TNFR:Fc administration reduced local levels of multiple proinflammatory cytokines and osteoclast-like cells at the periodontal lesions. These findings suggest that delivery of AAV2/1-TNFR:Fc may be a viable approach to modulate periodontal disease progression.Keywords
This publication has 56 references indexed in Scilit:
- Host‐Response Therapeutics for Periodontal DiseasesThe Journal of Periodontology, 2008
- Three‐Dimensional Micro‐Computed Tomographic Imaging of Alveolar Bone in Experimental Bone Loss or RepairThe Journal of Periodontology, 2007
- Long-term Suppression of Experimental Arthritis Following Intramuscular Administration of a Pseudotyped AAV2/1-TNFR:Fc VectorMolecular Therapy, 2007
- The dual role of p55 tumour necrosis factor-α receptor inActinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destructionClinical and Experimental Immunology, 2006
- B and T Lymphocytes Are the Primary Sources of RANKL in the Bone Resorptive Lesion of Periodontal DiseaseThe American Journal of Pathology, 2006
- Tumor Necrosis Factor Inhibitors for Rheumatoid ArthritisNew England Journal of Medicine, 2006
- Treatment of human disease by adeno-associated viral gene transferHuman Genetics, 2006
- New insights into the molecular mechanism of interleukin-10-mediated immunosuppressionJournal of Leukocyte Biology, 2004
- Toll-like Receptor 4-Mediated Signal Pathway Induced by Porphyromonas gingivalis Lipopolysaccharide in Human Gingival FibroblastsBiochemical and Biophysical Research Communications, 2000
- The Bacterial Etiology of Destructive Periodontal Disease: Current ConceptsThe Journal of Periodontology, 1992